The global Cytotoxicity Testing market size was valued at US$ 15280 million in 2024 and is forecast to a readjusted size of USD 26370 million by 2031 with a CAGR of 8.2% during review period.
The Cytotoxicity Test is designed to evaluate the general toxicity of medical devices and materials. Testing involves extracting devices in a cell culture media and then exposing the extract fluid to mouse fibroblast cells.
Cytotoxicity Testing Market: Growing Demand Driven by Rising Pharmaceutical R&D and Regulatory Stringency
The global cytotoxicity testing market is expected to witness significant growth in the coming years, fueled by several key factors:
Rising pharmaceutical research and development: Increased investments in drug discovery and development are leading to a higher demand for cytotoxicity testing services to assess the safety and efficacy of new drugs.
Stringent regulatory requirements: Regulatory agencies like the FDA and EMA are imposing stricter regulations on the safety of drugs and medical devices, mandating comprehensive cytotoxicity testing.
Growing awareness of safety concerns: Increasing awareness about the potential toxicity of drugs, medical devices, and consumer products is driving the demand for cytotoxicity testing to ensure the safety of these products.
Advances in technology: Technological advancements are leading to the development of more sensitive, specific, and high-throughput cytotoxicity testing methods, making them more efficient and cost-effective.
Outsourcing trend: Pharmaceutical and biotechnology companies are increasingly outsourcing their cytotoxicity testing needs to specialized contract research organizations (CROs) due to expertise and cost considerations.
Market Trends:
Integration of automation and data analytics: Integrating cytotoxicity testing with automation and data analytics systems is enhancing efficiency, data traceability, and decision-making capabilities.
Focus on high-throughput screening (HTS): HTS methods are increasingly being used to screen large libraries of compounds for potential cytotoxicity, leading to faster drug discovery and development.
Development of 3D cell culture models: 3D cell culture models are becoming increasingly popular for cytotoxicity testing as they provide a more realistic environment for assessing the effects of substances on living cells.
Focus on personalized medicine: Personalized cytotoxicity testing approaches are being developed to tailor testing protocols to individual patients based on their genetic makeup and other factors.
Technological advancements: Advancements in areas like microfluidics and nanotechnology are leading to the development of new and improved cytotoxicity testing methods.
Challenges and Opportunities:
Stringent regulatory compliance requirements: Maintaining compliance with evolving regulatory requirements can be challenging for testing laboratories, requiring continuous investments in technology and expertise.
Competition from new entrants: The market is becoming increasingly competitive with the entry of new players, putting pressure on established companies to innovate and offer cost-effective solutions.
Rapid technological advancements: Keeping pace with rapid technological advancements and the constant evolution of testing methods requires significant investments in research and development.
The future of the cytotoxicity testing market is optimistic, driven by the increasing demand for safe and effective drugs, medical devices, and consumer products, stringent regulatory requirements, and ongoing technological advancements. By focusing on innovation, automation, cost-effectiveness, and expansion into emerging markets, testing service providers can ensure their competitiveness and contribute to enhancing patient safety and product quality.
This report is a detailed and comprehensive analysis for global Cytotoxicity Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cytotoxicity Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cytotoxicity Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cytotoxicity Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cytotoxicity Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cytotoxicity Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cytotoxicity Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs, NorthEast BioLab, Biosafe Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cytotoxicity Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Market segment by Application
Medical Device
Medical Accessories
Others
Market segment by players, this report covers
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÃœV SÃœD
Medicilon
Huatongwei
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cytotoxicity Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cytotoxicity Testing, with revenue, gross margin, and global market share of Cytotoxicity Testing from 2020 to 2025.
Chapter 3, the Cytotoxicity Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cytotoxicity Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cytotoxicity Testing.
Chapter 13, to describe Cytotoxicity Testing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cytotoxicity Testing by Type
1.3.1 Overview: Global Cytotoxicity Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cytotoxicity Testing Consumption Value Market Share by Type in 2024
1.3.3 Elution Testing Method
1.3.4 Agar Overlay Method
1.3.5 Direct Contact Method
1.3.6 MTT Assay Method
1.3.7 Others
1.4 Global Cytotoxicity Testing Market by Application
1.4.1 Overview: Global Cytotoxicity Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical Device
1.4.3 Medical Accessories
1.4.4 Others
1.5 Global Cytotoxicity Testing Market Size & Forecast
1.6 Global Cytotoxicity Testing Market Size and Forecast by Region
1.6.1 Global Cytotoxicity Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cytotoxicity Testing Market Size by Region, (2020-2031)
1.6.3 North America Cytotoxicity Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Cytotoxicity Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cytotoxicity Testing Market Size and Prospect (2020-2031)
1.6.6 South America Cytotoxicity Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cytotoxicity Testing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Sartorius
2.1.1 Sartorius Details
2.1.2 Sartorius Major Business
2.1.3 Sartorius Cytotoxicity Testing Product and Solutions
2.1.4 Sartorius Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sartorius Recent Developments and Future Plans
2.2 UL
2.2.1 UL Details
2.2.2 UL Major Business
2.2.3 UL Cytotoxicity Testing Product and Solutions
2.2.4 UL Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 UL Recent Developments and Future Plans
2.3 Eurofins
2.3.1 Eurofins Details
2.3.2 Eurofins Major Business
2.3.3 Eurofins Cytotoxicity Testing Product and Solutions
2.3.4 Eurofins Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Eurofins Recent Developments and Future Plans
2.4 SGS
2.4.1 SGS Details
2.4.2 SGS Major Business
2.4.3 SGS Cytotoxicity Testing Product and Solutions
2.4.4 SGS Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 SGS Recent Developments and Future Plans
2.5 Emery Pharma
2.5.1 Emery Pharma Details
2.5.2 Emery Pharma Major Business
2.5.3 Emery Pharma Cytotoxicity Testing Product and Solutions
2.5.4 Emery Pharma Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Emery Pharma Recent Developments and Future Plans
2.6 Nelson Labs
2.6.1 Nelson Labs Details
2.6.2 Nelson Labs Major Business
2.6.3 Nelson Labs Cytotoxicity Testing Product and Solutions
2.6.4 Nelson Labs Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Nelson Labs Recent Developments and Future Plans
2.7 UFAG Laboratorien AG
2.7.1 UFAG Laboratorien AG Details
2.7.2 UFAG Laboratorien AG Major Business
2.7.3 UFAG Laboratorien AG Cytotoxicity Testing Product and Solutions
2.7.4 UFAG Laboratorien AG Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 UFAG Laboratorien AG Recent Developments and Future Plans
2.8 Pacific BioLabs
2.8.1 Pacific BioLabs Details
2.8.2 Pacific BioLabs Major Business
2.8.3 Pacific BioLabs Cytotoxicity Testing Product and Solutions
2.8.4 Pacific BioLabs Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Pacific BioLabs Recent Developments and Future Plans
2.9 NorthEast BioLab
2.9.1 NorthEast BioLab Details
2.9.2 NorthEast BioLab Major Business
2.9.3 NorthEast BioLab Cytotoxicity Testing Product and Solutions
2.9.4 NorthEast BioLab Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 NorthEast BioLab Recent Developments and Future Plans
2.10 Biosafe Ltd
2.10.1 Biosafe Ltd Details
2.10.2 Biosafe Ltd Major Business
2.10.3 Biosafe Ltd Cytotoxicity Testing Product and Solutions
2.10.4 Biosafe Ltd Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Biosafe Ltd Recent Developments and Future Plans
2.11 Creative Bioarray
2.11.1 Creative Bioarray Details
2.11.2 Creative Bioarray Major Business
2.11.3 Creative Bioarray Cytotoxicity Testing Product and Solutions
2.11.4 Creative Bioarray Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Creative Bioarray Recent Developments and Future Plans
2.12 Evercyte
2.12.1 Evercyte Details
2.12.2 Evercyte Major Business
2.12.3 Evercyte Cytotoxicity Testing Product and Solutions
2.12.4 Evercyte Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Evercyte Recent Developments and Future Plans
2.13 IONTOX
2.13.1 IONTOX Details
2.13.2 IONTOX Major Business
2.13.3 IONTOX Cytotoxicity Testing Product and Solutions
2.13.4 IONTOX Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 IONTOX Recent Developments and Future Plans
2.14 Applied StemCell
2.14.1 Applied StemCell Details
2.14.2 Applied StemCell Major Business
2.14.3 Applied StemCell Cytotoxicity Testing Product and Solutions
2.14.4 Applied StemCell Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Applied StemCell Recent Developments and Future Plans
2.15 Xenometrix AG
2.15.1 Xenometrix AG Details
2.15.2 Xenometrix AG Major Business
2.15.3 Xenometrix AG Cytotoxicity Testing Product and Solutions
2.15.4 Xenometrix AG Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Xenometrix AG Recent Developments and Future Plans
2.16 TÃœV SÃœD
2.16.1 TÃœV SÃœD Details
2.16.2 TÃœV SÃœD Major Business
2.16.3 TÃœV SÃœD Cytotoxicity Testing Product and Solutions
2.16.4 TÃœV SÃœD Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 TÃœV SÃœD Recent Developments and Future Plans
2.17 Medicilon
2.17.1 Medicilon Details
2.17.2 Medicilon Major Business
2.17.3 Medicilon Cytotoxicity Testing Product and Solutions
2.17.4 Medicilon Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Medicilon Recent Developments and Future Plans
2.18 Huatongwei
2.18.1 Huatongwei Details
2.18.2 Huatongwei Major Business
2.18.3 Huatongwei Cytotoxicity Testing Product and Solutions
2.18.4 Huatongwei Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Huatongwei Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cytotoxicity Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Cytotoxicity Testing by Company Revenue
3.2.2 Top 3 Cytotoxicity Testing Players Market Share in 2024
3.2.3 Top 6 Cytotoxicity Testing Players Market Share in 2024
3.3 Cytotoxicity Testing Market: Overall Company Footprint Analysis
3.3.1 Cytotoxicity Testing Market: Region Footprint
3.3.2 Cytotoxicity Testing Market: Company Product Type Footprint
3.3.3 Cytotoxicity Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cytotoxicity Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Cytotoxicity Testing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Cytotoxicity Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Cytotoxicity Testing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Cytotoxicity Testing Consumption Value by Type (2020-2031)
6.2 North America Cytotoxicity Testing Market Size by Application (2020-2031)
6.3 North America Cytotoxicity Testing Market Size by Country
6.3.1 North America Cytotoxicity Testing Consumption Value by Country (2020-2031)
6.3.2 United States Cytotoxicity Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Cytotoxicity Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Cytotoxicity Testing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Cytotoxicity Testing Consumption Value by Type (2020-2031)
7.2 Europe Cytotoxicity Testing Consumption Value by Application (2020-2031)
7.3 Europe Cytotoxicity Testing Market Size by Country
7.3.1 Europe Cytotoxicity Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Cytotoxicity Testing Market Size and Forecast (2020-2031)
7.3.3 France Cytotoxicity Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Cytotoxicity Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Cytotoxicity Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Cytotoxicity Testing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Cytotoxicity Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cytotoxicity Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Cytotoxicity Testing Market Size by Region
8.3.1 Asia-Pacific Cytotoxicity Testing Consumption Value by Region (2020-2031)
8.3.2 China Cytotoxicity Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Cytotoxicity Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Cytotoxicity Testing Market Size and Forecast (2020-2031)
8.3.5 India Cytotoxicity Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cytotoxicity Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Cytotoxicity Testing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Cytotoxicity Testing Consumption Value by Type (2020-2031)
9.2 South America Cytotoxicity Testing Consumption Value by Application (2020-2031)
9.3 South America Cytotoxicity Testing Market Size by Country
9.3.1 South America Cytotoxicity Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Cytotoxicity Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Cytotoxicity Testing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Cytotoxicity Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cytotoxicity Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Cytotoxicity Testing Market Size by Country
10.3.1 Middle East & Africa Cytotoxicity Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Cytotoxicity Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cytotoxicity Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Cytotoxicity Testing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Cytotoxicity Testing Market Drivers
11.2 Cytotoxicity Testing Market Restraints
11.3 Cytotoxicity Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Cytotoxicity Testing Industry Chain
12.2 Cytotoxicity Testing Upstream Analysis
12.3 Cytotoxicity Testing Midstream Analysis
12.4 Cytotoxicity Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÃœV SÃœD
Medicilon
Huatongwei
Ìý
Ìý
*If Applicable.
